Sonia Burrel

InstitutionSorbonne Université
AddressParis
France
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 23 Covid-19 publications, with a maximum of 4 publications in July 2020
    All Publications
    Bar chart showing 51 publications over 12 distinct years, with a maximum of 12 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Marot S, Malet I, Leducq V, Abdi B, Teyssou E, Soulie C, Wirden M, Rodriguez C, Fourati S, Pawlotsky JM, Boutolleau D, Burrel S, Calvez V, Marcelin AG, Jary A. Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare Workers. Clin Infect Dis. 2022 03 01; 74(4):707-710. PMID: 34050731.
      Citations: 4     Fields:    
    2. Paccoud O, Tubach F, Baptiste A, Bleibtreu A, Hajage D, Monsel G, Tebano G, Boutolleau D, Klement E, Godefroy N, Palich R, Itani O, Faiçal A, Valantin MA, Tubiana R, Burrel S, Calvez V, Caumes E, Marcelin AG, Pourcher V. Compassionate Use of Hydroxychloroquine in Clinical Practice for Patients With Mild to Severe COVID-19 in a French University Hospital. Clin Infect Dis. 2021 12 06; 73(11):e4064-e4072. PMID: 32556143.
      Citations: 22     Fields:    Translation:Humans
    3. Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann HH, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Haljasmägi L, Migaud M, Särekannu K, Maslovskaja J, de Prost N, Tandjaoui-Lambiotte Y, Luyt CE, Amador-Borrero B, Gaudet A, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier JC, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux PL, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya JM, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs C, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 08 19; 6(62). PMID: 34413139.
      Citations: 28     Fields:    Translation:Humans
    4. Marot S, Malet I, Leducq V, Zafilaza K, Sterlin D, Planas D, Gothland A, Jary A, Dorgham K, Bruel T, Burrel S, Boutolleau D, Schwartz O, Gorochov G, Calvez V, Marcelin AG. Author Correction: Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers. Nat Commun. 2021 May 10; 12(1):2824. PMID: 33972561.
      Citations: 1     Fields:    
    5. Teyssou E, Soulie C, Visseaux B, Lambert-Niclot S, Ferre V, Marot S, Jary A, Sayon S, Zafilaza K, Leducq V, Schnuriger A, Abdi B, Wirden M, Houhou-Fidouh N, Charpentier C, Morand-Joubert L, Burrel S, Descamps D, Calvez V, Marcelin AG. The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients. J Infect. 2021 Jul; 83(1):119-145. PMID: 33932451.
      Citations: 4     Fields:    Translation:Humans
    6. Dorgham K, Quentric P, Gökkaya M, Marot S, Parizot C, Sauce D, Guihot A, Luyt CE, Schmidt M, Mayaux J, Beurton A, Le Guennec L, Demeret S, Ben Salah E, Mathian A, Yssel H, Combadiere B, Combadiere C, Traidl-Hoffmann C, Burrel S, Marcelin AG, Amoura Z, Voiriot G, Neumann AU, Gorochov G. Distinct cytokine profiles associated with COVID-19 severity and mortality. J Allergy Clin Immunol. 2021 06; 147(6):2098-2107. PMID: 33894209.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    7. Citations: 1     Fields:    Translation:Humans
    8. Gaymard A, Bosetti P, Feri A, Destras G, Enouf V, Andronico A, Burrel S, Behillil S, Sauvage C, Bal A, Morfin F, Van Der Werf S, Josset L, Blanquart F, Coignard B, Cauchemez S, Lina B. Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021. Euro Surveill. 2021 03; 26(9). PMID: 33663644.
      Citations: 19     Fields:    Translation:Humans
    9. de Prost N, Bastard P, Arrestier R, Fourati S, Mahévas M, Burrel S, Dorgham K, Gorochov G, Tandjaoui-Lambiotte Y, Azzaoui I, Fernandes I, Combes A, Casanova JL, Mekontso-Dessap A, Luyt CE. Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia. J Clin Immunol. 2021 04; 41(3):536-544. PMID: 33616813.
      Citations: 17     Fields:    Translation:Humans
    10. Marot S, Malet I, Leducq V, Zafilaza K, Sterlin D, Planas D, Gothland A, Jary A, Dorgham K, Bruel T, Burrel S, Boutolleau D, Schwartz O, Gorochov G, Calvez V, Marcelin AG. Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers. Nat Commun. 2021 02 08; 12(1):844. PMID: 33558507.
      Citations: 46     Fields:    Translation:HumansCells
    11. Marot S, Calvez V, Louet M, Marcelin AG, Burrel S. Interpretation of SARS-CoV-2 replication according to RT-PCR crossing threshold value. Clin Microbiol Infect. 2021 07; 27(7):1056-1057. PMID: 33524586.
      Citations: 3     Fields:    Translation:Humans
    12. Klement E, Godefroy N, Burrel S, Kornblum D, Monsel G, Bleibtreu A, Marcelin AG, Calvez V, Caumes E, Boutolleau D, Pourcher V. The First Locally Acquired Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Healthcare Worker in the Paris Area. Clin Infect Dis. 2020 12 03; 71(9):e530-e531. PMID: 32211789.
      Citations: 4     Fields:    Translation:Humans
    13. Luyt CE, Sahnoun T, Gautier M, Vidal P, Burrel S, Pineton de Chambrun M, Chommeloux J, Desnos C, Arzoine J, Nieszkowska A, Bréchot N, Schmidt M, Hekimian G, Boutolleau D, Robert J, Combes A, Chastre J. Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study. Ann Intensive Care. 2020 Nov 23; 10(1):158. PMID: 33230710.
      Citations: 23     
    14. Burrel S, Hausfater P, Dres M, Pourcher V, Luyt CE, Teyssou E, Soulié C, Calvez V, Marcelin AG, Boutolleau D. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19. Int J Infect Dis. 2021 Jan; 102:10-13. PMID: 33115679.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    15. Hékimian G, Kerneis M, Zeitouni M, Cohen-Aubart F, Chommeloux J, Bréchot N, Mathian A, Lebreton G, Schmidt M, Hié M, Silvain J, Pineton de Chambrun M, Haroche J, Burrel S, Marot S, Luyt CE, Leprince P, Amoura Z, Montalescot G, Redheuil A, Combes A. Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units. Chest. 2021 02; 159(2):657-662. PMID: 32910974.
      Citations: 15     Fields:    Translation:Humans
    16. Faury H, Courboulès C, Payen M, Jary A, Hausfater P, Luyt C, Dres M, Pourcher V, Abdi B, Wirden M, Calvez V, Marcelin AG, Boutolleau D, Burrel S. Medical features of COVID-19 and influenza infection: A comparative study in Paris, France. J Infect. 2021 02; 82(2):e36-e39. PMID: 32798533.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    17. Dres M, Burrel S, Boutolleau D, Voiriot G, Demoule A, Combes A, Lebreton G, Schmidt M. SARS-CoV-2 Does Not Spread Through Extracorporeal Membrane Oxygenation or Dialysis Membranes. Am J Respir Crit Care Med. 2020 08 01; 202(3):458-460. PMID: 32525400.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    18. Cancella de Abreu M, Choquet C, Petit H, Bouzid D, Damond F, Marot S, Ferre VM, Burrel S, Boutolleau D, Houdou-Fidouh N, Marcelin AG, Descamps D, Hausfater P. SARS-CoV-2 IGM and IGG rapid serologic test for the diagnosis of COVID-19 in the emergency department. J Infect. 2020 11; 81(5):816-846. PMID: 32739490.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    19. Jary A, Leducq V, Malet I, Marot S, Klement-Frutos E, Teyssou E, Soulié C, Abdi B, Wirden M, Pourcher V, Caumes E, Calvez V, Burrel S, Marcelin AG, Boutolleau D. Evolution of viral quasispecies during SARS-CoV-2 infection. Clin Microbiol Infect. 2020 Nov; 26(11):1560.e1-1560.e4. PMID: 32717416.
      Citations: 31     Fields:    Translation:HumansCellsPHPublic Health
    20. Chougar L, Shor N, Weiss N, Galanaud D, Leclercq D, Mathon B, Belkacem S, Ströer S, Burrel S, Boutolleau D, Demoule A, Rosso C, Delorme C, Seilhean D, Dormont D, Morawiec E, Raux M, Demeret S, Gerber S, Trunet S, Similowski T, Degos V, Rufat P, Corvol JC, Lehéricy S, Pyatigorskaya N. Retrospective Observational Study of Brain MRI Findings in Patients with Acute SARS-CoV-2 Infection and Neurologic Manifestations. Radiology. 2020 12; 297(3):E313-E323. PMID: 32677875.
      Citations: 39     Fields:    Translation:HumansCellsPHPublic Health
    21. Lecronier M, Beurton A, Burrel S, Haudebourg L, Deleris R, Le Marec J, Virolle S, Nemlaghi S, Bureau C, Mora P, De Sarcus M, Clovet O, Duceau B, Grisot PH, Pari MH, Arzoine J, Clarac U, Boutolleau D, Raux M, Delemazure J, Faure M, Decavele M, Morawiec E, Mayaux J, Demoule A, Dres M. Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis. Crit Care. 2020 07 11; 24(1):418. PMID: 32653015.
      Citations: 19     Fields:    Translation:HumansPHPublic Health
    22. Jary A, Flandre P, Chabouis A, Nguyen S, Marot S, Burrel S, Boutolleau D, Calvez V, Marcelin AG, Louet M. Clinical presentation of Covid-19 in health care workers from a French University Hospital. J Infect. 2020 09; 81(3):e61-e63. PMID: 32579992.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    23. Klement-Frutos E, Burrel S, Peytavin G, Marot S, Lê MP, Godefroy N, Calvez V, Marcelin AG, Caumes E, Pourcher V, Boutolleau D. Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19. J Infect. 2021 01; 82(1):159-198. PMID: 32473230.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    24. Nouchi A, Monsel G, Lafon-Desmurs B, Meng L, Burrel S, Moyal-Barracco M, Caumes E. Epstein-Barr Virus-related Acute Genital Ulcer Successfully Treated with Colchicine. Acta Derm Venereol. 2018 01 12; 98(1):134-135. PMID: 28795759.
      Citations: 4     Fields:    Translation:HumansCells
    25. Mercier-Darty M, Boutolleau D, Lepeule R, Rodriguez C, Burrel S. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations. Antiviral Res. 2018 03; 151:20-23. PMID: 29337163.
      Citations: 2     Fields:    Translation:HumansCells
    26. Deback C, Rousseau A, Breckler M, Molet L, Boutolleau D, Burrel S, Roque-Afonso AM, Labetoulle M. Antiviral effects of Cacicol®, a heparan sulfate biomimetic for corneal regeneration therapy, for herpes simplex virus type-1 and varicella zoster virus infection. Antivir Ther. 2018; 23(8):665-675. PMID: 30028308.
      Citations: 1     Fields:    Translation:AnimalsCells
    27. Afshar B, Bibby DF, Piorkowska R, Ohemeng-Kumi N, Snoeck R, Andrei G, Gillemot S, Morfin F, Frobert E, Burrel S, Boutolleau D, Crowley B, Mbisa JL. A European multi-centre External Quality Assessment (EQA) study on phenotypic and genotypic methods used for Herpes Simplex Virus (HSV) drug resistance testing. J Clin Virol. 2017 11; 96:89-93. PMID: 29031157.
      Citations: 1     Fields:    Translation:HumansCells
    28. Rousseau A, Boutolleau D, Titier K, Bourcier T, Chiquet C, Weber M, Colin J, Gueudry J, M'Garrech M, Bodaghi B, Burrel S, Agut H, Deback C, Labetoulle M. Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study. Antiviral Res. 2017 Oct; 146:205-212. PMID: 28939476.
      Citations: 3     Fields:    Translation:HumansCells
    29. Burrel S, Boutolleau D, Ryu D, Agut H, Merkel K, Leendertz FH, Calvignac-Spencer S. Ancient Recombination Events between Human Herpes Simplex Viruses. Mol Biol Evol. 2017 07 01; 34(7):1713-1721. PMID: 28369565.
      Citations: 23     Fields:    Translation:Cells
    30. Troché G, Marque Juillet S, Burrel S, Boutolleau D, Bédos JP, Legriel S. Herpes simplex virus type 2: Cluster of unrelated cases in an intensive care unit. Am J Infect Control. 2016 10 01; 44(10):1178-1180. PMID: 27198455.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    31. Perrier M, Désiré N, Deback C, Agut H, Boutolleau D, Burrel S. Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals. J Virol Methods. 2016 Jul; 233:10-4. PMID: 26994966.
      Citations:    Fields:    Translation:HumansCells
    32. Collot M, Rouard C, Brunet C, Agut H, Boutolleau D, Burrel S. High conservation of herpes simplex virus UL5/UL52 helicase-primase complex in the era of new antiviral therapies. Antiviral Res. 2016 Apr; 128:1-6. PMID: 26826441.
      Citations: 2     Fields:    Translation:HumansCells
    33. Agut H, Burrel S, Boutolleau D. Tenofovir Gel to Prevent HSV-2 Infection. N Engl J Med. 2015 11 12; 373(20):1980. PMID: 26559586.
      Citations:    Fields:    Translation:HumansCells
    34. Burrel S, Désiré N, Marlet J, Dacheux L, Seang S, Caumes E, Bourhy H, Agut H, Boutolleau D. Genetic Diversity within Alphaherpesviruses: Characterization of a Novel Variant of Herpes Simplex Virus 2. J Virol. 2015 Dec; 89(24):12273-83. PMID: 26401046.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    35. Frobert E, Burrel S, Ducastelle-Lepretre S, Billaud G, Ader F, Casalegno JS, Nave V, Boutolleau D, Michallet M, Lina B, Morfin F. Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in France. Antiviral Res. 2014 Nov; 111:36-41. PMID: 25218782.
      Citations: 28     Fields:    Translation:HumansCells
    36. Pilorgé L, Burrel S, Aït-Arkoub Z, Agut H, Boutolleau D. Human cytomegalovirus (CMV) susceptibility to currently approved antiviral drugs does not impact on CMV terminase complex polymorphism. Antiviral Res. 2014 Nov; 111:8-12. PMID: 25194992.
      Citations: 8     Fields:    Translation:HumansCells
    37. Abrão EP, Burrel S, Désiré N, Bonnafous P, Godet A, Caumes E, Agut H, Boutolleau D. Impact of HIV-1 infection on herpes simplex virus type 2 genetic variability among co-infected individuals. J Med Virol. 2015 Mar; 87(3):357-65. PMID: 25174847.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    38. Deback C, Burrel S, Varnous S, Carcelain G, Conan F, Aït-Arkoub Z, Autran B, Gandjbakhch I, Agut H, Boutolleau D. Management of multidrug-resistant CMV infection in immunocompromised patients: case report of a heart-transplant recipient and review of the literature. Antivir Ther. 2015; 20(2):249-54. PMID: 25219330.
      Citations: 1     Fields:    Translation:HumansCells
    39. Burrel S, Rouard C, Boutolleau D. Helicase-primase inhibitor pritelivir for HSV-2 infection. N Engl J Med. 2014 Apr 24; 370(17):1663-4. PMID: 24758629.
      Citations: 2     Fields:    Translation:HumansCells
    40. Seang S, Boutolleau D, Burrel S, Regnier S, Epelboin L, Voujon D, Valantin MA, Katlama C, Agut H, Caumes E. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection. Int J STD AIDS. 2014 Aug; 25(9):676-82. PMID: 24535691.
      Citations: 1     Fields:    Translation:Humans
    41. Burrel S, Brunet C, Hamm N, Gits-Muselli M, Hermet L, Aimé C, Agut H, Boutolleau D. Validation of the QIAsymphony RGQ system for DNA quantitation of different BK virus genotypes in whole blood samples. J Virol Methods. 2014 Feb; 196:32-5. PMID: 24184087.
      Citations: 1     Fields:    Translation:HumansCells
    42. Burrel S, Aime C, Hermet L, Ait-Arkoub Z, Agut H, Boutolleau D. Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey. Antiviral Res. 2013 Nov; 100(2):365-72. PMID: 24075863.
      Citations: 16     Fields:    Translation:HumansCells
    43. Burrel S, Ait-Arkoub Z, Voujon D, Deback C, Abrao EP, Agut H, Boutolleau D. Molecular characterization of herpes simplex virus 2 strains by analysis of microsatellite polymorphism. J Clin Microbiol. 2013 Nov; 51(11):3616-23. PMID: 23966512.
      Citations: 9     Fields:    Translation:HumansCells
    44. Burrel S, Boutolleau D, Azar G, Doan S, Deback C, Cochereau I, Agut H, Gabison EE. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis. J Clin Virol. 2013 Sep; 58(1):321-4. PMID: 23731845.
      Citations: 10     Fields:    Translation:HumansCells
    45. Burrel S, Abrao EP, Désiré N, Seang S, Caumes E, Agut H, Boutolleau D. Detection of a new variant of herpes simplex virus type 2 among HIV-1-infected individuals. J Clin Virol. 2013 Jul; 57(3):267-9. PMID: 23567026.
      Citations: 7     Fields:    Translation:HumansCells
    46. Burrel S, Bonnafous P, Hubacek P, Agut H, Boutolleau D. Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity. Antiviral Res. 2012 Dec; 96(3):386-90. PMID: 23041200.
      Citations: 4     Fields:    Translation:Cells
    47. Burrel S, Fovet C, Brunet C, Ovaguimian L, Hamm N, Conan F, Kalkias L, Agut H, Boutolleau D. Routine use of duplex real-time PCR assays including a commercial internal control for molecular diagnosis of opportunistic DNA virus infections. J Virol Methods. 2012 Oct; 185(1):136-41. PMID: 22766177.
      Citations: 2     Fields:    Translation:Humans
    48. Boutolleau D, Canestri A, Burrel S, Wirden M, Seang S, Clavel-Osorio C, Marcelin AG, Katlama C, Agut H. Emergence of cytomegalovirus resistance to foscarnet in a patient receiving foscarnet salvage therapy for multidrug-resistant HIV infection. J Clin Virol. 2012 Jun; 54(2):194-6. PMID: 22398036.
      Citations: 1     Fields:    Translation:HumansCells
    49. Burrel S, Aït-Arkoub Z, Agut H, Boutolleau D. Genotypic characterization of herpes simplex virus DNA polymerase UL42 processivity factor. Antiviral Res. 2012 Jan; 93(1):199-203. PMID: 22061617.
      Citations: 2     Fields:    Translation:HumansCells
    50. Boutolleau D, Burrel S, Agut H. Genotypic characterization of human cytomegalovirus UL97 phosphotransferase natural polymorphism in the era of ganciclovir and maribavir. Antiviral Res. 2011 Jul; 91(1):32-5. PMID: 21570426.
      Citations: 4     Fields:    Translation:HumansCells
    51. Burrel S, Deback C, Agut H, Boutolleau D. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals. Antimicrob Agents Chemother. 2010 Nov; 54(11):4833-42. PMID: 20733037.
      Citations: 23     Fields:    Translation:HumansCells
    Burrel's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (161)
    Explore
    _
    Co-Authors (384)
    Explore
    _
    Similar People (60)
    Explore
    _